Crossmark

Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9 ® to Suppress Enzalutamide-resistant Prostate Cancer Progression

Crossref DOI link: https://doi.org/10.1016/j.eururo.2017.04.005

Published Print: 2017-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wang, Ronghao

Sun, Yin

Li, Lei

Niu, Yuanjie

Lin, Wanying

Lin, Changyi

Antonarakis, Emmanuel S.

Luo, Jun

Yeh, Shuyuan

Chang, Chawnshang
License Information

Text and Data Mining valid from 2017-11-01
More Information

This article is maintained by: Elsevier

Article Title: Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression

Journal Title: European Urology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eururo.2017.04.005

Content Type: article

Copyright: © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below